Results 61 to 70 of about 278,909 (163)

A PGRPLC1/Rel2-F axis controls Anopheles gambiae resistance to systemic infections with Gram-positive bacteria containing Lys-type peptidoglycan.

open access: yesPLoS Pathogens
In the Afrotropical malaria vector Anopheles gambiae s.l., the Imd pathway plays pleiotropic roles in immunity, including resistance to malaria parasites, that are mediated by its NF-κB transcription factor Rel2. Rel2 exists as a full-length form (Rel2-F)
Amani Audi   +3 more
doaj   +1 more source

Hybrids of copper cysteamine nanosheets and silver nanocluster ensure superior bactericidal capability via enhanced photodynamic effect

open access: yesScientific Reports
Over the past decades, bacterial infections resulting from the misuse of antibiotics have garnered significant attention. Among the alternative antibacterial strategies, photodynamic therapy (PDT) has emerged as a promising non-antibiotic approach ...
Jie Wang   +7 more
doaj   +1 more source

OCULAR INFECTIONS: RATIONAL APPROACH TO ANTIBIOTIC THERAPY

open access: yesNational Journal of Medical Research, 2012
Background: Isolation of common pathogens involved in ocular infection and their in-vitro susceptibility to commonly used ocular antibiotics, as well as the trends in antibiotic resistance developed by these pathogens were investigated.
Mulla Summaiya A   +2 more
doaj  

Clinical Characteristics and Early Evolution of Neonates with Perinatal Gram-Negative Bacterial Infections. [PDF]

open access: yesChildren (Basel)
Zaharie M   +6 more
europepmc   +1 more source

Correction: Barani et al. Nanomaterials in the Management of Gram-Negative Bacterial Infections. <i>Nanomaterials</i> 2021, <i>11</i>, 2535. [PDF]

open access: yesNanomaterials (Basel)
Barani M   +8 more
europepmc   +1 more source

Effects of renal impairment and hemodialysis on the pharmacokinetics and safety of HRS-8427, a siderophore cephalosporin for Gram-negative bacterial infections. [PDF]

open access: yesAntimicrob Agents Chemother
Wu Y   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy